Hepatocyte growth factor (HGF) modulates GABAergic inhibition and seizure susceptibility

Experimental Neurology

Volumn 221, Issue 1, 2010, Pages 129-135

  Bae, Mihyun H ^a   Bissonette, Gregory B ^a,b   Mars, Wendy M ^c   Michalopoulos, George K ^c   Achim, Cristian L ^d   Depireux, Didier A ^e   Powell, Elizabeth M ^a,b  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF MARYLAND   (United States)

^c UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e UNIVERSITY OF MARYLAND   (United States)

Author keywords

Autism; EEG; Epilepsy; GABA; HGF SF; Interneuron; Met; Parvalbumin; Seizure; Urokinase

Indexed keywords

SCATTER FACTOR; UROKINASE RECEPTOR;

ADULT ANIMAL; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BIRTH DEFECT; CELL COUNT; CELL POPULATION; CONTROLLED STUDY; ELECTROENCEPHALOGRAM; EPILEPSY; FOREBRAIN; GABAERGIC SYSTEM; INTERNEURON; MALE; MOUSE; NEOCORTEX; NEUROLOGIC DISEASE; NONHUMAN; ONTOGENY; PERINATAL PERIOD; PRIORITY JOURNAL; SEIZURE SUSCEPTIBILITY;

ACTION POTENTIALS; ANALYSIS OF VARIANCE; ANIMALS; ANIMALS, GENETICALLY MODIFIED; ANIMALS, NEWBORN; AVOIDANCE LEARNING; BRAIN; DISEASE SUSCEPTIBILITY; ELECTROENCEPHALOGRAPHY; ENZYME-LINKED IMMUNOSORBENT ASSAY; GAMMA-AMINOBUTYRIC ACID; GLIAL FIBRILLARY ACIDIC PROTEIN; HEPATOCYTE GROWTH FACTOR; HUMANS; INTERNEURONS; MICE; NEURAL INHIBITION; PARVALBUMINS; PENTYLENETETRAZOLE; REACTION TIME; RECEPTORS, UROKINASE PLASMINOGEN ACTIVATOR; SEIZURES;

EID: 72749115898     PISSN: 00144886     EISSN: 10902430     Source Type: Journal    
DOI: 10.1016/j.expneurol.2009.10.011     Document Type: Article

References (43)

1. Abounader R., and Laterra J. Scatter factor/hepatocyte growth factor in brain tumor growth and angiogenesis. Neuro. Oncol. 7 (2005) 436-451
2. Achim C.L., Katyal S., Wiley C.A., Shiratori M., Wang G., Oshika E., Petersen B.E., Li J.M., and Michalopoulos G.K. Expression of HGF and cMet in the developing and adult brain. Brain Res. Dev. Brain Res. 102 (1997) 299-303
3. Arrieta O., Garcia E., Guevara P., Garcia-Navarrete R., Ondarza R., Rembao D., and Sotelo J. Hepatocyte growth factor is associated with poor prognosis of malignant gliomas and is a predictor for recurrence of meningioma. Cancer 94 (2002) 3210-3218
4. Beschorner R., Schluesener H.J., Nguyen T.D., Magdolen V., Luther T., Pedal I., Mattern R., Meyermann R., and Schwab J.M. Lesion-associated accumulation of uPAR/CD87- expressing infiltrating granulocytes, activated microglial cells/macrophages and upregulation by endothelial cells following TBI and FCI in humans. Neuropathol. Appl. Neurobiol. 26 (2000) 522-527
5. Blasi F., and Carmeliet P. uPAR: a versatile signalling orchestrator. Nat. Rev. Mol. Cell Biol. 3 (2002) 932-943
6. Bothe G.W.M., Bolivar V.J., Vedder M.J., and Geistfeld J.G. Genetic and behavioral differences among five inbred mouse strains commonly used in the production of transgenic and knockout mice. Genes Brain Behav. 3 (2004) 149-157
7. Campbell D.B., D'Oronzio R., Garbett K., Ebert P.J., Mirnics K., Levitt P., and Persico A.M. Disruption of cerebral cortex MET signaling in autism spectrum disorder. Ann. Neurol. 62 (2007) 243-250
8. Campbell D.B., Li C., Sutcliffe J.S., Persico A.M., and Levitt P. Genetic evidence implicating multiple genes in the MET receptor tyrosine kinase pathway in autism spectrum disorder. Autism Res. 1 (2008) 159-168
9. Canty A.J., Dietze J., Harvey M., Enomoto H., Milbrandt J., and Ibanez C.F. Regionalized loss of parvalbumin interneurons in the cerebral cortex of mice with deficits in GFRalpha1 signaling. J. Neurosci. 29 (2009) 10695-10705
10. Cobos I., Calcagnotto M.E., Vilaythong A.J., Thwin M.T., Noebels J.L., Baraban S.C., and Rubenstein J.L. Mice lacking Dlx1 show subtype-specific loss of interneurons, reduced inhibition and epilepsy. Nat. Neurosci. 8 (2005) 1059-1068
11. Comoglio P.M., Tamagnone L., and Boccaccio C. Plasminogen-related growth factor and semaphorin receptors: a gene superfamily controlling invasive growth. Exp. Cell Res. 253 (1999) 88-99
12. Crawley J.N. What's Wrong with my Mouse? Behavioral Phenotyping of Transgenic and Knockout Mice (2000), Wiley-Liss, New York
13. Dono R., Texido G., Dussel R., Ehmke H., and Zeller R. Impaired cerebral cortex development and blood pressure regulation in FGF-2-deficient mice. EMBO J. 17 (1998) 4213-4225
14. Eagleson K.L., Bonnin A., and Levitt P. Region- and age-specific deficits in gamma-aminobutyric acidergic neuron development in the telencephalon of the uPAR(-/-) mouse. J. Comp. Neurol. 489 (2005) 449-466
15. Ellis V., Behrendt N., and Dano K. Plasminogen activation by receptor-bound urokinase. A kinetic study with both cell-associated and isolated receptor. J. Biol. Chem. 266 (1991) 12752-12758
16. Erickson J.C., Clegg K.E., and Palmiter R.D. Sensitivity to leptin and susceptibility to seizures of mice lacking neuropeptide Y. Nature 381 (1996) 415-421
17. Garbelli R., Meroni A., Magnaghi G., Beolchi M.S., Ferrario A., Tassi L., Bramerio M., and Spreafico R. Architectural (Type IA) focal cortical dysplasia and parvalbumin immunostaining in temporal lobe epilepsy. Epilepsia 47 (2006) 1074-1078
18. Guerrero J., Santibanez J.F., Gonzalez A., and Martinez J. EGF receptor transactivation by urokinase receptor stimulus through a mechanism involving Src and matrix metalloproteinases. Exp. Cell Res. 292 (2004) 201-208
19. Gutierrez H., Dolcet X., Tolcos M., and Davies A. HGF regulates the development of cortical pyramidal dendrites. Development 131 (2004) 3717-3726
20. Haunso A., Ibrahim M., Bartsch U., Letiembre M., Celio M.R., and Menoud P. Morphology of perineuronal nets in tenascin-R and parvalbumin single and double knockout mice. Brain Res. 864 (2000) 142-145
21. Holmes A., Wrenn C.C., Harris A.P., Thayer K.E., and Crawley J.N. Behavioral profiles of inbred strains on novel olfactory, spatial and emotional tests for reference memory in mice. Genes Brain Behav. 1 (2002) 55-69
22. Homanics G.E., Quinlan J.J., and Firestone L.L. Pharmacologic and behavioral responses of inbred C57BL/6J and strain 129/SvJ mouse lines. Pharmacol. Biochem. Behav. 63 (1999) 21-26
23. Jo M., Thomas K.S., O'Donnell D.M., and Gonias S.L. Epidermal growth factor receptor-dependent and -independent cell-signaling pathways originating from the urokinase receptor. J. Biol. Chem. 278 (2003) 1642-1646
24. Jones K.R., Farinas I., Backus C., and Reichardt L.F. Targeted disruption of the BDNF gene perturbs brain and sensory neuron development but not motor neuron development. Cell 76 (1994) 989-999
25. Judson M.C., Bergman M.Y., Campbell D.B., Eagleson K.L., and Levitt P. Dynamic gene and protein expression patterns of the autism-associated met receptor tyrosine kinase in the developing mouse forebrain. J. Comp. Neurol. 513 (2009) 511-531
26. Kubota Y., Hattori R., and Yui Y. Three distinct subpopulations of GABAergic neurons in rat frontal agranular cortex. Brain Res. 649 (1994) 159-173
27. Lahtinen L., Huusko N., Myohanen H., Lehtivarjo A.K., Pellinen R., Turunen M.P., Yla-Herttuala S., Pirinen E., and Pitkanen A. Expression of urokinase-type plasminogen activator receptor is increased during epileptogenesis in the rat hippocampus. Neuroscience 163 (2009) 316-328
28. Lim C.S., and Walikonis R.S. Hepatocyte growth factor and c-Met promote dendritic maturation during hippocampal neuron differentiation via the Akt pathway. Cell Signal 20 (2008) 825-835
29. Mars W.M., Zarnegar R., and Michalopoulos G.K. Activation of hepatocyte growth factor by the plasminogen activators uPA and tPA. Am. J. Pathol. 143 (1993) 949-958
30. Mars W.M., Liu M.L., Kitson R.P., Goldfarb R.H., Gabauer M.K., and Michalopoulos G.K. Immediate early detection of urokinase receptor after partial hepatectomy and its implications for initiation of liver regeneration. Hepatology 21 (1995) 1695-1701
31. Mathis C., Paul S., and Crawley J.N. Characterization of benzodiazepine-sensitive behaviors in the A/J and C57BL/6J inbred strains of mice. Behav. Genet. 24 (1994) 171-180
32. Monga S.P., Mars W.M., Pediaditakis P., Bell A., Mule K., Bowen W.C., Wang X., Zarnegar R., and Michalopoulos G.K. Hepatocyte growth factor induces Wnt-independent nuclear translocation of beta-catenin after Met-beta-catenin dissociation in hepatocytes. Cancer Res. 62 (2002) 2064-2071
33. Paxinos G., and Franklin K.B.J. The mouse brain in stereotaxic coordinates (2001), Academic Press, San Diego
34. Powell E.M., Campbell D.B., Stanwood G.D., Davis C., Noebels J.L., and Levitt P. Genetic disruption of cortical interneuron development causes region- and GABA cell type-specific deficits, epilepsy, and behavioral dysfunction. J. Neurosci. 23 (2003) 622-631
35. Powell E.M., Mars W.M., and Levitt P. Hepatocyte growth factor/scatter factor is a motogen for interneurons migrating from the ventral to dorsal telencephalon. Neuron 30 (2001) 79-89
36. Schwaller B., Tetko I.V., Tandon P., Silveira D.C., Vreugdenhil M., Henzi T., Potier M.C., Celio M.R., and Villa A.E. Parvalbumin deficiency affects network properties resulting in increased susceptibility to epileptic seizures. Mol. Cell Neurosci. 25 (2004) 650-663
37. Simon D.I., Wei Y., Zhang L., Rao N.K., Xu H., Chen Z., Liu Q., Rosenberg S., and Chapman H.A. Identification of a urokinase receptor-integrin interaction site. Promiscuous regulator of integrin function. J. Biol. Chem. 275 (2000) 10228-10234
38. Sun W., Funakoshi H., and Nakamura T. Differential expression of hepatocyte growth factor and its receptor, c-Met in the rat retina during development. Brain Res. 851 (1999) 46-53
39. Wahlsten D., Metten P., Phillips T.J., Boehm S.L., Burkhart-Kasch S., Dorow J., Doerksen S., Downing C., Fogarty J., Rodd-Henricks K., Hen R., McKinnon C.S., Merrill C.M., Nolte C., Schalomon M., Schlumbohm J.P., Sibert J.R., Wenger C.D., Dudek B.C., and Crabbe J.C. Different data from different labs: lessons from studies of gene-environment interaction. J. Neurobiol. 54 (2003) 283-311
40. Walker D.G., Lue L.F., and Beach T.G. Increased expression of the urokinase plasminogen-activator receptor in amyloid beta peptide-treated human brain microglia and in AD brains. Brain Res. 926 (2002) 69-79
41. Weiss J.H., Koh J., Baimbridge K.G., and Choi D.W. Cortical neurons containing somatostatin- or parvalbumin-like immunoreactivity are atypically vulnerable to excitotoxic injury in vitro. Neurology 40 (1990) 1288-1292
42. West M.J. Stereological methods for estimating the total number of neurons and synapses: issues of precision and bias. Trends Neurosci. 22 (1999) 51-61
43. Wonders C.P., and Anderson S.A. The origin and specification of cortical interneurons. Nat. Rev. Neurosci. 7 (2006) 687-696